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The factors that regulate trophoblast invasion of the uterine vasculature are incompletely understood. In this paper we show that macaque
trophoblasts express the mucin, MUC1, and that it is involved in trophoblast-endothelial interaction. Immunocytochemistry, Western blotting and
RT-PCR analyses confirmed that MUC1 was expressed by isolated early gestation macaque trophoblasts. MUC1 was also detected in
endovascular trophoblasts in sections of placental–decidual tissue during early gestation. A blocking antibody against MUC1 reduced trophoblast
adhesion to uterine endothelial cells and also blocked trophoblast transendothelial migration. MUC1 is known to bind to Intercellular Adhesion
Molecule-1 (ICAM-1) in other systems. Incubation in the presence of a blocking antibody against Intercellular Adhesion Molecule-1 (ICAM-1) or
recombinant ICAM-1 modestly, but significantly, reduced transendothelial trophoblast migration. These results are consistent with the idea that
MUC1 is involved in trophoblast adhesion to uterine endothelial cells and in trophoblast transendothelial migration.
© 2007 Elsevier B.V. All rights reserved.Keywords: Adhesion; Placenta; Uterus; Mucins1. Introduction
The mucin, MUC1, is a Type 1 transmembrane protein
expressed on the apical surface of a wide variety of normal
glandular epithelial cells and is overexpressed in a non-
polarized fashion in many tumor cells [1]. MUC1 is also
expressed by activated T-cells [2] and dendritic cells [3,4].
Because of its large size and unusual physical properties
resulting from extensive O-glycosylation of the variable tandem
repeat region, MUC1 is generally thought of as having
lubricating or anti-adhesive effects on cell–cell and cell–
substrate interactions [5–8]. In tumor cells, the anti-adhesive
effects of MUC1 are thought to facilitate metastasis [7,9]. In the
female reproductive tract, MUC1 is expressed by the uterine
epithelium where it plays roles in protecting against infection⁎ Corresponding author. Department of Cell Biology and Human Anatomy,
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is refractory to implantation but generalized (in the mouse) or
localized (in the human) loss of MUC1 during the window of
implantation is associated with blastocyst attachment [10–13].
Ambiguously, other data suggest that MUC1 may facilitate
cell–cell adhesion. MUC1 has been shown to bind intercellular
adhesion molecule-1 (ICAM-1) and E-selectin [14]. In the latter
case, binding is likely due to the presentation of sialyl Lewis(x)
or sialyl Lewis(a) antigens by MUC1 [15]. Uterine MUC1 has
been shown to present selectin ligands that may function in
blastocyst attachment [16]. The adhesion of tumor cells to
endothelium was shown to be blocked by anti-MUC1 and anti-
ICAM-1 antibodies [17,18]. MUC1 and ICAM-1 also appear to
be involved in regulating transendothelial migration of breast
carcinoma cells [19].
In human and non-human primates, blastocyst attachment to
the endometrial epithelium is followed by trophoblast invasion
of the endometrium and endometrial vasculature. The attach-
ment of endovascular trophoblasts to endothelium and their
migration within the uterine vasculature is a physiologically
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between trophoblasts and endothelial cells is important for
normal placental development and for establishing a blood
supply to the developing fetus. Several candidate adhesion
molecule systems have been proposed to play a role in
trophoblast-endothelial cell adhesion [20–26]. In vitro adhesion
assays using human and macaque trophoblasts suggest that
trophoblast-endothelial adhesion involves β1 integrin, αVβ3
integrin, VE-cadherin, and VCAM-1 [27–30].
Human villous and extravillous trophoblasts and mouse
trophoblasts express MUC1 [31–33]. These observations have
attracted little attention and, to date, no studies have
investigated the role of MUC1 in trophoblast adhesion and
migration. We have therefore tested the idea that MUC1 is
expressed by early gestation macaque trophoblasts and that it
plays a role in the attachment of trophoblasts to endothelium.
The results show that macaque trophoblasts express MUC1 and
that trophoblast-endothelial cell adhesion and trophoblast
transendothelial migration are mediated by MUC1.
2. Materials and methods
2.1. Trophoblast Isolation and Culture
All procedures involving animals were performed in accordance with the
NIH Guide for the Care and Use of Laboratory Animals and under the approval
of the University of California Davis, Animal Care and Use Committee.
Trophoblast cells were isolated from 40 to 65 days Rhesus monkey (Macaca
mulatta) placental/decidual tissue using procedures we have previously detailed
[34]. FACS analysis of the purified trophoblast population revealed that 75% of
the cells were β1 integrin-positive [35], consistent with a predominantly
extravillous trophoblast phenotype.
2.2. Endothelial cell culture
Human uterine microvascular endothelial cells (UtMVECs, passage 3) were
purchased from Clonetics Corporation (San Diego, CA) and maintained in
endothelial basal medium-2 (EBM-2, Clonetics) supplemented with human
recombinant epidermal growth factor, human fibroblast growth factor, vascular
endothelial growth factor, ascorbic acid (Vitamin C), hydrocortisone, human
recombinant insulin-like growth factor, heparin, gentamicin, amphotercin, and
5% fetal calf serum (FCS). Cells between passages 5 and 10 were used for
experiments.
2.3. Immunocytochemistry
A hamster polyclonal antibody (CT2) against the cytoplasmic domain of
MUC1 was generously provided by Dr. Sandra Gendler, Mayo Clinic, Arizona.
The mouse monoclonal antibody B27.29 was provided by Fujirebio
Diagnostics, Inc., Malvern, PA, and was raised against a partially purified
mucin fraction from the ascites fluid of a cancer patient. This antibody
recognizes a sequence within the MUC1 tandem repeat domain [36].
Monoclonal antibodies against Leukocyte Function Antigen-1 (LFA-1) were
obtained from Abcam (Cambridge MA).
For immunofluorescence staining, adherent cells on 8-chamber LabTek
culture slides were first fixed with ice-cold methanol for 10 min (for CT2 and all
other antibodies except B27.29) or with 4% paraformaldehyde for 15 min (for
B27.29). The slides were then washed in PBS and incubated overnight with
primary antibodies (each at 10 μg/ml) followed by incubation with secondary
antibodies for 1 h. Primary antibody controls consisting of isotype-matched
mouse or Armenian hamster immunoglobulins (Abcam, Cambridge, MA) were
always included. Primary antibodies were detected using FITC-labeled goat
anti-hamster IgG (Abcam, Cambridge MA) or AlexaFluor-488-labeled goatanti-mouse IgG antibodies (Invitrogen Corporation, Carlsbad CA). For some
experiments, cells were double-stained using anti-MUC1 antibody and rabbit
anti-cytokeratin (Zymed, San Francisco CA). The rabbit anti-cytokeratin was
detected using an AlexaFluor-594-labeled goat anti-rabbit antibody.
2.4. Immunohistochemistry
Immunohistochemical staining was performed on sections of paraffin-embedded
tissues. Placentas and attached decidua basalis were obtained from four animals
(Macaca mulatta) on days 30–40 of pregnancy. Tissues were fixed in phosphate-
buffered 4% paraformaldehyde for 4 h, rinsed in phosphate buffer, and embedded in
paraffin. After sectioning (6 μm) of paraffin-embedded tissues, slides were de-
paraffinized and rehydrated. Some of these specimens were made available to us by
Dr. Allen Enders in the form of archived paraffin-embedded blocks and sections.
Prior to immunostaining for MUC1, sections were immersed in 10 mM
sodium citrate, pH 6.0, and heated to 100 °C for 10 min using a microwave oven.
The sections were allowed to cool for 15 min then washed with PBS. For
detection of cytokeratin, sections were incubated with pepsin (1 mg/ml) in
10 mM Tris–HCl, pH 2.0 for 10 min and then washed with PBS. Sections were
incubated overnight with the anti-MUC1 antibody (CT2, see above), a rabbit
anti-cytokeratin antibody (Zymed), or a monoclonal anti-Platelet Endothelial
Cell Adhesion Molecule-1 (PECAM-1) antibody (DAKO, Carpinteria CA).
Control sections were incubated with non-immune Armenian hamster Ig or
rabbit Ig. Antibodies were used at 10 μg/ml. After washing, the sections were
incubated with a FITC-conjugated rabbit anti-Armenian hamster Ig antibody, an
AlexaFluor-488-conjugated goat anti-rabbit Ig, or an AlexaFluor-488-conju-
gated goat anti-mouse Ig for 1 h. After further washing, the sections were
mounted in glycerol-based medium and viewed with a fluorescence microscope.
Detection of MUC1 in archived paraffin-embedded sections that had been stored
for greater than 2 years was unsatisfactory due to high levels of autofluorescence
that could not be reduced. However, autofluorescence was significantly reduced
if archived blocks from the same specimens were freshly re-sectioned.
2.5. RT-PCR analysis
Trophoblasts were cultured for 2 days. Messenger RNAwas extracted from
the cells (50×106) using a Poly(A)Pure kit (Ambion Inc., Austin TX). Three
hundred ng mRNAwas denatured by heating to 70 °C for 10 min. The denatured
mRNAwas then reverse transcribed in a total volume of 20 μl containing DTT
(10 mM), dGTP, dCTP, dTTP, and dATP (1 mM each), random hexamers (5 μM;
GE Healthcare Bio-Sciences Corp. Piscataway, NJ), RNasin (1 U/ìl; Promega
Biosciences, San Luis Obispo CA) and 1X RT buffer with the addition of 200 U
SuperScript II Reverse Transcriptase (Invitrogen, Carlsbad CA) for 2 h at 42 °C.
To control for genomic contamination, H2O was substituted for reverse
transcriptase. The reaction was terminated by incubation at 70 °C for 15 min.
For PCR, 2 μl of the resultant cDNA was amplified in a 50-μl reaction
volume containing AccuPower PCR PreMix (Bionexus, Inc., Oakland CA) and
50 pmol each of anti-sense and sense primers for MUC1. Two sequential
(nested) PCR reactions were carried out. Primers designated MUC1-3-5′ and
MUC1-4-3’were used for the first reaction and primers MUC1-1-5′ and MUC1-
2-3’ were used for the second reaction (see below). For the first PCR reaction,
conditions were 95 °C for 5 min and then 35 cycles of: 95 °C, 20 s, 50 °C, 30 s,
72 °C, 1 min, 72 °C, 7 min, 4 °C, hold. For the second PCR reaction, conditions
were: 95 °C for 5 min followed by 35 cycles of 95 °C, 20 s, 46 °C, 30 s, 72 °C,
1 min, 72 °C, 7 min, and 4 °C, hold. PCR reaction products were analyzed on
2% agarose gels and ethidium bromide-stained bands were photographed.
2.6. MUC1 primer design
Two sets of primers directed against the highly conserved cytoplasmic tail
region of humanMUC1were prepared. PrimersMUC1-1-5′ andMUC1-2-3′were
modified (restriction sites were removed) from published primer sequences [37]
and yield a 207-bp amplicon. Primers MUC1-3-5′ and MUC1-4-3′ were based on
published sequences [38]. Primer Sequences were: MUC1-1-5′: 5′-
CCGCCGAAAGAACTACGG, MUC1-2-3′ : 5′-CAAAGTTGGCA-
GAAGTGGC; MUC1-3-5′: 5′-AACCTCCAGTTTAATTCCTCTCTGGA,
MUC1-4-3′: 5′-CTACAAGTTGGCAGAAGT.
Fig. 1. Immunofluorescence detection of MUC1 in isolated macaque
trophoblasts. Trophoblast cells were cultured for 24 h then stained with CT2
(A) or B27.29 (E) anti-MUC1 antibodies and viewed by immunofluorescence
microscopy (see Materials and methods). The immunofluorescence images C
and G show cells incubated with the corresponding control immunoglobulins.
The images in the right-hand column are the respective matching phase contrast
views. The horizontal bar represents 50 μm. The images are typical
representatives from four separate experiments.
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Cultures were washed with Dulbecco's Modified PBS containing Ca2+ and
Mg2+. The cells were then lysed on ice by the addition of M-PER Mammalian
Protein Extraction Reagent (Pierce Biochemicals, Rockford IL) supplemented
with 1% Protease Inhibitor Cocktail (Sigma-Aldrich Co, St. Louis MO). The
lysate was homogenized by repeated passage through a 27 gauge needle, then
mixed with an equal volume of Laemmli sample buffer (BioRad Laboratories,
Hercules CA) containing 5% β-mercaptoethanol and heated in a boiling water
bath for 5 min. The samples were immediately chilled on ice and loaded on to
SDS-polyacrylamide gels (Gradiopore; 8%; Promega, San Luis Obispo, CA) at
20 μg protein per lane. After electrophoresis the proteins were transferred to
nitrocellulose membrane (BioRad, Hercules CA). The membrane was blocked
for 1 h in 1% non-fat dried milk solution. The blocked membrane was incubated
overnight with the anti-MUC1 antibody (CT2, see above), then washed and
incubated with rabbit anti-Armenian hamster IgG labeled with horseradish
peroxidase (Abcam, Cambridge MA). After further washing, the membrane was
incubated with chemiluminescent substrate (SuperSignal West Dura; Pierce) for
5 min at room temperature. The membrane was then exposed to X-ray film
(Pierce). Band intensities were quantified using Kodak 1D software (Kodak
Imaging Systems, New Haven CT).
2.8. Cell–cell adhesion assay
Trophoblast adhesion to confluent endothelial cell monolayers was carried
using the fluorescence-based assay described previously [27] but with some
modifications. Endothelial cells (UtMVECs) were plated (20,000 cells per well)
and cultured for 24–48 h until confluent. Prior to use in experiments, UtMVECs
were incubated with Tumor Necrosis Factor-α (TNF-α) (10 ng/ml) for 12 h.
Trophoblasts were incubated with 10 μMCFDA-SE Cell Tracer Kit (Invitrogen,
Carlsbad CA) for 15 min in PBS at 37 °C, then washed in EBM containing 1%
bovine serum albumin and added (250,000 cells per well) to the confluent
UtMVEC cultures in a 96-well dish. The cells were incubated at 37 °C for 2 h
and non-adherent cells were removed by gentle washing. The dish was then
placed in a Millipore 2300 fluorescence plate reader and fluorescence values
were obtained. Trophoblast adhesion was expressed as a percentage of the total
fluorescence of the input cells.
For antibody blocking experiments, trophoblasts were labeled with CFDA-
SE as above and then pre-incubated with azide-free blocking antibodies (50 μg/
ml) for 20 min. After washing, the trophoblasts were added to the endothelial
monolayers as just described. In some experiments, the endothelial cells were
pre-incubated with blocking antibodies for 20 min prior to the additions of the
labeled trophoblasts. The blocking antibodies (azide-free) used were sheep anti-
Intercellular Adhesion Molecule-1 (ICAM-1; R&D Systems, Minneapolis,
MN), monoclonal anti-E-selectin (Chemicon Inc., Temecula, CA), and anti-
MUC1 (B27.29 and DF3; Fuziribio Inc).
2.9. Transmigration assay
Endothelial cells (20,000 cells per insert) were cultured to confluency on
3 μm pore size FluoroBlok inserts coated with Matrigel (BD Biosciences, San
Jose CA). Trophoblasts were labeled in suspension with Vybrant CFDA-SE
(Invitrogen) then incubated with blocking antibodies or recombinant ICAM-1 as
described above. In some cases the endothelial cells were pre-incubated with
anti-ICAM-1 antibody. The labeled trophoblasts were then added (250,000 cells
per insert) to the adherent endothelial monolayers (pre-incubated with TNF-α as
described above). The cells were co-cultured for different times at 37 °C.
Antibodies were present throughout the incubation. At each time point, the
culture plate was placed in a Cytofluor 2300 plate reader and the level of
fluorescence in the lower chamber was measured. The level of fluorescence in
the lower chamber provides a direct measure of trophoblast invasion which was
expressed as a percentage of the total fluorescence of the input trophoblasts.
2.10. Statistical analyses
All experiments were repeated at least 3 times using cells from different
placentas in each case. Cells from different placentas were not pooled. Statisticalanalysis was performed by one-way ANOVA followed by Tukey–Kramer
multiple comparison and linear trend post-tests using the Prism software
program (GraphPad Inc., San Diego, CA). Two-way repeated measures ANOVA
with Bonferroni post-testing, or non-linear regression analysis was used for
some data. Data are expressed as means±SEMs and differences were considered
significant if pb0.05.
3. Results
3.1. Expression of MUC1 by macaque trophoblasts
Fig. 1A shows the MUC1 immunofluorescence pattern when
cultures of adherent early gestation trophoblasts were permea-
bilized and stained with an antibody raised against the
cytoplasmic domain of MUC1. Punctate staining was promi-
nent around and over nuclei whereas a more diffuse pattern was
seen in the cytoplasm. A matching bright field image is shown
1010 T.L. Thirkill et al. / Biochimica et Biophysica Acta 1773 (2007) 1007–1014in Fig. 1B. Fig. 1C and D shows an immunoglobulin control and
corresponding bright field, respectively. Fig. 1E shows more
discreet punctate fluorescence when non-permeabilized cells
were stained with the B27.29 antibody raised against the
extracellular domain of MUC1. Staining appeared to be largely
over the nucleus and little or no staining was evident over the
cytoplasm. Fig. 1F shows the corresponding bright field image.
An antibody control and corresponding bright field image are
shown in Fig. 1G and H, respectively.
Sections of early gestation macaque placental/decidual tissue
were also stained with anti-MUC1 antibody (CT2) andFig. 2. Immunofluorescence detection of MUC1 in macaque placental/decidual tissu
with antibodies against MUC1 (CT2), PECAM-1, or cytokeratin as described in Mate
anti-MUC1 antibody are also illustrated. Panels A–D show a typical large uterine gla
M–O show a different invaded vessel at higher magnification. Panels P–S show a no
asterisks indicate the location of the corresponding vessel lumen in adjacent sectionexamined by immunofluorescence microscopy. Adjacent sec-
tions were incubated with control immunoglobulin for the
MUC1 antibody and with antibodies against PECAM-1 and
cytokeratin. As expected, and as reported by others [39], strong
MUC1 staining was found associated with epithelial cells on the
decidual surface and epithelial cells lining uterine glands. An
example of the latter is shown in Fig. 2A. Uterine epithelial cells
did not stain using the control immunoglobulin (Fig. 2B) and
were negative for PECAM-1 (Fig. 2C). As expected, uterine
epithelium was also positive for cytokeratin (Fig. 2D).
Examination of freshly sectioned villous tissue incubated withe. Serial sections of paraffin-embedded placental/decidual tissues were stained
rials and methods. The results of incubation with control immunoglobulin for the
nd. Panels E–H show villous tissue. Panels I–L show an invaded artery. Panels
n-invaded vessel. The arrow indicates endothelium stained with PECAM-1. The
s. The bars represent 50 μm.
Fig. 3. Analysis of MUC1 expression in trophoblasts by Western blot and RT-
PCR. (A) Trophoblast lysates and human Jar choriocarcinoma cell lysates were
examined by Western blot using the CT2 anti-MUC1 antibody (see Materials
and methods). A representative blot is shown. (B) Total RNAwas extracted from
macaque trophoblast cultures and reverse transcribed. The resulting cDNAwas
used as a template for PCR using primers directed against MUC1 as described in
Materials and methods. PCR products were analyzed on 2% agarose gels. DNA
standards (Std; left lane) were included. The middle lane shows that no band was
produced in the absence of reverse transcription (RT−). The right lane (RT+)
shows a prominent band of the predicted size (207 bp). The band was excised
from the gel and sequenced. The sequence data confirmed identity with MUC1.
Fig. 4. Effect of anti-MUC1 antibody on trophoblast adhesion to endothelial
cells. Trophoblasts were labeled with the fluorescent cell tracer CFDA-SE and
added to confluent endothelial (UtMVEC) monolayers as described in Materials
and methods. Adhesion was measured after 2 h. For some experiments
trophoblasts were pre-incubated with anti-MUC1 antibody or with recombinant
human ICAM-1 (rICAM-1). In other experiments the endothelial cells were pre-
incubated with anti-ICAM-1 or anti-E-selectin (E-sel). Adhesion is expressed as
a percentage of the initial input trophoblasts and values are means±SEMs from
3 experiments. Data were analyzed by ANOVA with Dunnett's Multiple
comparison post-test. Values marked with an asterisk were significantly different
from the control (pb0.01).
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staining of the trophoblast layer that was often difficult to
distinguish from the control (Fig. 2F). Villous trophoblasts were
positive for PECAM-1 as previously reported [24] and were
also positive for cytokeratin (Fig. 2G and H, respectively).
Fig. 2I–L shows a series of sections through a uterine blood
vessel heavily invaded by trophoblasts. Large numbers of
PECAM-1-positive and cytokeratin-positive trophoblasts can
be seen. Positive MUC1 staining (Fig. 2I) was associated with
trophoblasts closest to the vessel lumen. Staining intensity was
less than that seen for uterine epithelial cells but could readily be
distinguished from the antibody control. Fig. 2M–P shows
another invaded vessel at higher magnification. Again, positive
MUC1 staining was found for trophoblasts lining the vessel
lumen. For comparison, Fig. 2Q–T shows the immunofluores-
cence staining pattern of a non-invaded artery. The endothelium
is clearly identified by positive PECAM-1 staining (Fig. 2S,
arrow) but there is no cytokeratin staining (Fig. 2T) and no
MUC1 staining (Fig. 2Q) associated with this vessel profile. We
did not observe MUC1 staining within the trophoblastic shell
(not shown).
Expression of MUC1 by isolated macaque trophoblasts was
also assessed by Western blot analysis using the CT2 antibody
(Fig. 3A). Two bands with molecular masses between 30 kDaand 15 kDa were detected. Two or more bands within this size
range are typically detected using this antibody in other MUC1-
expressing cells [40]. For comparison, MUC1 expression by
human trophoblast-derived Jar choriocarcinoma cells was also
examined (Fig. 3A). A smeared band was found possibly due to
greater expression of MUC1 by these cells.
Further confirmation of MUC1 expression by macaque
trophoblasts was carried out using RT-PCR analysis. Fig. 3B
shows that an amplicon of the predicted size (207 bp) was
produced (RT+). No band was detected in the absence of reverse
transcription (RT−) confirming the absence of genomic
material. The band was excised from the gel and sequence
data (not shown) confirmed the identity with MUC1.
3.2. MUC1 is involved in the adhesion of macaque trophoblasts
to endothelial cells
Trophoblast adhesion to uterine endothelial cells was
measured using a fluorescence-based assay that we have
described previously [27]. When trophoblasts were pre-
incubated with an antibody (B27.9) known to block MUC1-
mediated adhesion and then added to confluent endothelial cell
cultures, adhesion was significantly reduced (pb0.01) com-
pared to non-antibody treated cells (Fig. 4). Since B27.29 reacts
with the tandem repeat domain and with carbohydrate domains
[41] we repeated the experiment using another anti-MUC1
antibody (DF3) which only reacts with the DTRPAPGS core
peptide sequence. Adhesion was also significantly reduced
using this antibody (results not shown).
Since MUC1 has been reported to bind ICAM-1, we carried
out experiments to determine whether ICAM-1 was involved in
trophoblast-endothelial adhesion. When trophoblasts were
added to endothelial cells that had been pre-incubated with an
adhesion-blocking anti-ICAM antibody, adhesion was not
significantly different from the control. Two other commercial
anti-ICAM-1 antibodies were also without effect on trophoblast
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recombinant human ICAM-1 reduced subsequent binding to
endothelial cells but the effect was not quite statistically
significant (q=2.82, pN0.05). Increasing the concentration of
antibody or recombinant ICAM-1 did not change these results
(not shown). Pre-incubation of trophoblasts with the anti-
MUC1 antibody prior to incubation with recombinant ICAM-1
significantly reduced trophoblast adhesion compared to the
control but the extent of the effect was similar to that of the anti-
MUC1 antibody used alone. Pre-incubation of trophoblasts with
an antibody against LFA-1, a major ICAM-1 counter receptor,
failed to inhibit adhesion to endothelial cells (results not
shown). MUC-1 is also reported to bind to E-selectin [14], but
trophoblast adhesion was unaffected by pre-incubation of
endothelial cells with an adhesion-blocking antibody against
E-selectin (Fig. 4).
3.3. Treatment of trophoblasts with anti-MUC1 antibody
reduces transmigration across endothelial cell monolayers
We next examined the effects of the anti-MUC1 antibody on
the time course of trophoblast transmigration across endothe-
lium using commercial invasion chambers (Fig. 5). Mean
trophoblast migration values for each of the antibody-treated
co-cultures were consistently less than control values at all time
points. Regression analysis of these time course data indicated
that the anti-MUC1 antibody significantly (F=5.597; pb0.001)
reduced trophoblast migration and when individual time pointsFig. 5. Effect of anti-MUC1 antibody on trophoblast transendothelial migration.
Trophoblasts were labeled with the fluorescent cell tracer CFDA-SE and added
to confluent endothelial monolayers cultured on TransWell FluorBlok inserts.
Transendothelial migration of trophoblasts to the lower chamber was measured
at different time points as described in Materials and methods. For some
experiments trophoblasts were pre-incubated with anti-MUC1 antibody or with
recombinant human ICAM-1 (rICAM-1) and then added to the endothelial cells
without washing. In other experiments the endothelial cells were pre-incubated
with anti-ICAM-1 antibody which was maintained in the culture medium
throughout the experiment. Trophoblast migration is expressed as a percentage
of the initial input trophoblasts and values are means±SEMs from 3 to 4
experiments. Data were analyzed by non-linear regression with an F test. The
results are described in the text. Data were also evaluated by 2-way ANOVA
with a Bonferroni post-test. The asterisks indicate values that are significantly
different (pb0.05) from the corresponding control value.were analyzed by 2-way ANOVA, a significant effect of the
anti-MUC1 antibody was found at the 4, 5, and 6 h time points.
Regression analysis indicated that trophoblast migration was
significantly reduced by recombinant ICAM-1 (F=3.109,
pb0.05) and by the anti-ICAM-1 antibody (F=2.967,
pb0.05). Analysis by 2-way ANOVA showed that a significant
effect of the rICAM-1 and the anti-ICAM-1 antibody on
trophoblast migration was achieved at the 5- and 6-h, and the 6-
h time points, respectively.
4. Discussion
The results presented here demonstrate that early gestation
macaque trophoblasts express MUC1 and that MUC1 is
involved in trophoblast-endothelial interactions. In sections of
early gestation macaque placental/decidual tissue MUC1
expression was detected in endovascular trophoblasts but was
not found in the trophoblastic shell. MUC1 expression by
villous trophoblasts was often equivocal and weak at best.
Expression of MUC1 by human endovascular trophoblasts was
not reported although MUC1 was detected in first trimester
villous and extravillous trophoblasts [32]. The expression of
MUC1 by invasive trophoblasts in intact macaque tissue was
substantiated by showing robust MUC1 expression at the
protein and mRNA levels in isolated early gestation macaque
trophoblast cells. We have previously shown that these cells
have an invasive phenotype in vitro [35,42]. In addition to the
human placental study cited above, muc1 has also been shown
to be expressed by mouse labyrinthine trophoblast [33] and by
human trophectoderm [8]. The expression of MUC1 by
trophoblasts is rarely acknowledged but the expression of
MUC1 by invasive trophoblasts in the macaque is consistent
with the idea that it may be involved in mediating the interaction
between endovascular trophoblasts and uterine endothelium.
Our finding that an antibody known to block MUC1-
mediated adhesion in other systems also blocked trophoblast
adhesion to endothelial cells supports the idea that MUC1 on
trophoblasts is involved in trophoblast adhesion to endothelium.
Other molecules implicated in human and non-human primate
trophoblast attachment to endothelium include β1 integrin,
αVβ3 integrin, VE-cadherin, and VCAM-1 [27–30,43]. How
these different adhesion systems are orchestrated to allow
trophoblast attachment and migration along endothelium is not
known. Our data also suggest that MUC1 could be involved in
trophoblast transendothelial migration in vivo since the MUC1
antibody also reduced trophoblast migration across endothelial
monolayers. Trophoblast transendothelial migration is an
important step in the trophoblast-mediated remodeling of the
uterine vasculature. MUC1 has been reported to be involved in
tumor cell transmigration [19] and may play a role in T-cell
motility [2].
The identity of the endothelial counter-receptor for MUC1 is
clearly of significance. Since MUC1 has been reported to bind
to ICAM-1 [17,44] and ICAM-1 is expressed by endothelial
cells and involved in leukocyte transmigration, ICAM-1 was an
obvious counter-receptor candidate for trophoblast MUC1.
However, when endothelial cells were pre-incubated with an
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adhesion was observed. The finding that pre-incubation of
trophoblasts with recombinant ICAM-1 reduced adhesion
(albeit to a not quite statistically significant level) is suggestive
of some involvement of ICAM-1. The observation that the
combined effect of the anti-MUC1 antibody and recombinant
ICAM-1 on adhesion was not additive is consistent with the
idea that trophoblasts bind ICAM-1 via MUC1. We could find
no expression of the major ICAM-1 counter receptors, LFA-1
and MAC-1 by macaque trophoblasts and corresponding
blocking antibodies had no effect on trophoblast-endothelial
adhesion (results not shown). Stronger support for the
conclusion that ICAM-1 is involved in trophoblast-endothelial
interaction was provided by the modest, but statistically
significant, effect of recombinant ICAM-1 and anti-ICAM-1
on trophoblast transendothelial migration. Human MUC1 is
reported to bind to domain 1 of ICAM-1 [45] and this is the site
targeted by the antibody. Studies of T-cell migration across
ICAM-1−/− endothelioma cells [46] in which different ICAM-1
mutants had been re-expressed demonstrated that the extracel-
lular domain of ICAM-1 supports T cell adhesion while the
cytoplasmic tail was required for transendothelial migration. In
the present case it is possible that while trophoblast attachment
to endothelial cells shows minimal dependency on ICAM-1, the
interaction between trophoblasts and endothelial ICAM-1 is
sufficient to induce signaling activity in the ICAM-1 cytoplas-
mic domain which affects subsequent transmigration. In a paper
submitted for publication elsewhere, we show that endothelial
ICAM-1 expression and distribution are altered by co-culturing
UtMVECs with trophoblasts.
Other potential MUC1 ligands can be considered. Because of
extensive glycosylation, MUC1 can mediate binding to lectins.
Sialyl Lewis(x) [14,47] and the Thomsen–Friedenreich antigen
[48–50] are presented by MUC1 on the surface of certain tumor
cells and may promote adhesion to endothelial cells expressing
selectins and galectin-3, respectively [51–54]. We found no
evidence that E-selectin was involved in trophoblast-endothelial
attachment or that UtMVECs express either galectin-3 or
galectin-1 (immunofluorescence results not shown).
In summary, the results show that invasive trophoblasts in
the macaque express MUC1 and that MUC1 is involved in
trophoblast attachment to, and migration across, endothelium.
While our data support a modest role for endothelial ICAM-1 in
MUC1-mediated trophoblast adhesion and transmigration, the
data do not rule out the possibility of other as yet undiscovered
MUC-1 ligands on uterine endothelium.
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